Expression and Purification of Recombinant Human Mig in Escherichia Coli and Its Comparison with Murine Mig.
Lan Qian,Shunying Zhu,Jiaqing Shen,Xiaodong Han,Jin Gao,Mingyuan Wu,Yan Yu,Huili Lu,Wei Han
DOI: https://doi.org/10.1016/j.pep.2011.12.009
IF: 2.025
2012-01-01
Protein Expression and Purification
Abstract:Monokine induced by IFN-gamma (Mig) is a member of CXC-chemokines and recruits T-lymphocytes to activate the immune response. In recent years, it has raised much interest in the areas of autoimmune disease and allograft rejection, as the production of recombinant human Mig (rHuMig) would be of considerable significance for both research and potential clinical use. Here we report the expression, preparation and characterization of non-tagged recombinant human Mig (rHuMig) using a prokaryotic expression system. Following expression in Escherichia coli (E. coli) BL21. the 103 amino acid residue of rHuMig was purified from bacteria inclusion bodies with a one-step S-Sepharose cation exchange chromatography. The product was immunologically characterized via Western blot and its purity was determined via SOS-PAGE and silver staining to be above 99%, with an endotoxin level <0.5 EU/mu g via a chemotaxis assay, rHuMig demonstrated chemotactic activity on mouse spleen lymphocytes with an ED50 of 15 ng/mL. Additionally, using a proliferation assay, rHuMig significantly inhibited proliferation of the human bladder cell line T24. In vivo experiments revealed that rHuMig could inhibit mouse bone marrow mononuclear cells cycling into the S-phase and reduced intestinal cell proliferation. Our results demonstrate that rHuMig is fully functional in the mouse model. (C) 2012 Elsevier Inc. All rights reserved.